Ataxias

Clinics in Geriatric Medicine

Volumn 22, Issue 4, 2006, Pages 859-877

  Perlman, Susan L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMANTADINE; AMIODARONE; ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; BARBITURIC ACID DERIVATIVE; BUSPIRONE; CARBAMAZEPINE; CIMETIDINE; CLONAZEPAM; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; FLUOROURACIL; GABAPENTIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; ISONIAZID; LAMOTRIGINE; MEFLOQUINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHENYTOIN; PROPRANOLOL; TACROLIMUS; TOPIRAMATE; UNINDEXED DRUG; VIGABATRIN;

ANAMNESIS; ATAXIA; BLEEDING; BRAIN INFECTION; BRAIN INJURY; CEREBELLAR ATAXIA; CEREBELLUM; CEREBELLUM DISEASE; CEREBELLUM INFARCTION; CEREBELLUM TUMOR; CLINICAL FEATURE; COORDINATION DISORDER; ELECTRONYSTAGMOGRAPHY; ENDOCRINE DISEASE; GENETIC DISORDER; HEAD INJURY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SACCADIC EYE MOVEMENT; STROKE; TOXICOLOGY; TREMOR; X CHROMOSOME LINKAGE;

AGED; ATAXIA; HUMANS;

EID: 33748771729     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cger.2006.06.011     Document Type: Review

References (75)

1. Moseley M.L., Benzow K.A., Schut L.J., et al. Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia families. Neurology 51 6 (1998) 1666-1671
2. Jardim L.B., Silveira I., Pereira M.L., et al. A survey of spinocerebellar ataxia in South Brazil-66 new cases with Machado-Joseph disease, SCA7, SCA8, or unidentified disease-causing mutations. J Neurol 248 10 (2001) 870-876
3. Leggo J., Dalton A., Morrison P.J., et al. Analysis of spinocerebellar ataxia types 1, 2, 3, and 6, dentatorubral-pallidoluysian atrophy, and Friedreich's ataxia genes in spinocerebellar ataxia patients in the UK. J Med Genet 34 12 (1997) 982-985
4. Schols L., Gispert S., Vorgerd M., et al. Spinocerebellar ataxia type 2. Genotype and phenotype in German kindreds. Arch Neurol 54 9 (1997) 1073-1080
5. Schols L., Kruger R., Amoiridis G., et al. Spinocerebellar ataxia type 6: genotype and phenotype in German kindreds. J Neurol Neurosurg Psychiatry 64 1 (1998) 67-73
6. Schols L., Szymanski S., Peters S., et al. Genetic background of apparently idiopathic sporadic cerebellar ataxia. Hum Genet 107 2 (2000) 132-137
7. Giuffrida S., Saponara R., Trovato Salinaro A., et al. Identification of SCA2 mutation in cases of spinocerebellar ataxia with no family history in mid-eastern Sicily. Ital J Neurol Sci 20 4 (1999) 217-221
8. Pujana M.A., Corral J., Gratacos M., et al. Spinocerebellar ataxias in Spanish patients: genetic analysis of familial and sporadic cases. The Ataxia Study Group. Hum Genet 104 6 (1999) 516-522
9. Ramesar R.S., Bardien S., Beighton P., et al. Expanded CAG repeats in spinocerebellar ataxia (SCA1) segregate with distinct haplotypes in South African families. Hum Genet 100 1 (1997) 131-137
10. Futamura N., Matsumura R., Fujimoto Y., et al. CAG repeat expansions in patients with sporadic cerebellar ataxia. Acta Neurol Scand 98 1 (1998) 55-59
11. Hsieh M., Lin S.J., Chen J.F., et al. Identification of the spinocerebellar ataxia type 7 mutation in Taiwan: application of PCR-based Southern blot. J Neurol 247 8 (2000) 623-629
12. Soong B.W., Lu Y.C., Choo K.B., et al. Frequency analysis of autosomal dominant cerebellar ataxias in Taiwanese patients and clinical and molecular characterization of spinocerebellar ataxia type 6. Arch Neurol 58 7 (2001) 1105-1109
13. Storey E., du Sart D., Shaw J.H., et al. Frequency of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Australian patients with spinocerebellar ataxia. Am J Med Genet 95 4 (2000) 351-357
14. Maruyama H., Izumi Y., Morino H., et al. Difference in disease-free survival curve and regional distribution according to subtype of spinocerebellar ataxia: a study of 1,286 Japanese patients. Am J Med Genet 114 5 (2002) 578-583
15. Gray R.G., Preece M.A., Green S.H., et al. Inborn errors of metabolism as a cause of neurological disease in adults: an approach to investigation. J Neurol Neurosurg Psychiatry 69 1 (2000) 5-12
16. Jacquemont S., Hagerman R.J., Leehey M.A., et al. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA 291 4 (2004) 460-469
17. Sun G., Gargus J.J., Ta D.T., et al. Identification of a novel candidate gene in the iron-sulfur pathway implicated in ataxia-susceptibility: human gene encoding HscB, a J-type co-chaperone. J Hum Genet 48 8 (2003) 415-419
18. Chataway J., Sawcer S., Coraddu F., et al. Evidence that allelic variants of the spinocerebellar ataxia type 2 gene influence susceptibility to multiple sclerosis. Neurogenetics 2 2 (1999) 91-96
19. Jardim L., Silveira I., Pereira M.L., et al. Searching for modulating effects of SCA2, SCA6 and DRPLA CAG tracts on the Machado-Joseph disease (SCA3) phenotype. Acta Neurol Scand 107 3 (2003) 211-214
20. Li Y.J., Oliveira S.A., Xu P., et al. Glutathione S-transferase omega-1 modifiesage-at-onset of Alzheimer disease and Parkinson disease. Hum Mol Genet 12 24 (2003) 3259-3267
21. Mercuri E., He J., Curati W.L., et al. Cerebellar infarction and atrophy in infants and children with a history of premature birth. Pediatr Radiol 27 2 (1997) 139-143
22. Nelson K.B., and Lynch J.K. Stroke in newborn infants. Lancet Neurol 3 3 (2004) 150-158
23. Ozduman K., Pober B.R., Barnes P., et al. Fetal stroke. Pediatr Neurol 30 3 (2004) 151-162
24. Kinne S., Patrick D.L., and Doyle D.L. Prevalence of secondary conditions among people with disabilities. Am J Public Health 94 3 (2004) 443-445
25. Goldstein M. Traumatic brain injury: a silent epidemic. Ann Neurol 27 3 (1990) 327
26. Kraus J.F., Morgenstern H., Fife D., et al. Blood alcohol tests, prevalence of involvement, and outcomes following brain injury. Am J Public Health 79 3 (1989) 294-299
27. Tsai F.Y., Teal J.S., Itabashi H.H., et al. Computed tomography of posterior fossa trauma. J Comput Assist Tomogr 4 3 (1980) 291-305
28. Louis E.D., Lynch T., Ford B., et al. Delayed-onset cerebellar syndrome. Arch Neurol 53 5 (1996) 450-454
29. Kawata Y., Suzuki T., Kagaya H., et al. An MRI analysis of brain-stem and cerebellar lesions and olivary hypertrophy. Neuroradiology 38 5 (1996) 441-443
30. Bracchi M., Savoiardo M., Triulzi F., et al. Superficial siderosis of the CNS: MR diagnosis and clinical findings. AJNR Am J Neuroradiol 14 1 (1993) 227-236
31. Freeman W., and Jaffe D. Occlusion of superior cerebellar artery: report of a case with necropsy. Arch. Neurol. Psychiatry 46 (1941) 115-126
32. Andeweg J. Consequences of the anatomy of deep venous outflow from the brain. Neuroradiology 41 4 (1999) 233-241
33. Amarenco P. The spectrum of cerebellar infarctions. Neurology 41 7 (1991) 973-979
34. Hacke W., Zeumer H., Ferbert A., et al. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 19 10 (1988) 1216-1222
35. Askelof P., and Gillenius P. Effect of lymphocytosis-promoting factor from Bordetella pertussis on cerebellar cyclic GMP levels. Infect Immun 36 3 (1982) 958-961
36. Setta F., Baecke M., Jacquy J., et al. Cerebellar ataxia following whooping cough. Clin Neurol Neurosurg 101 1 (1999) 56-61
37. Tagliati M., Simpson D., Morgello S., et al. Cerebellar degeneration associated with human immunodeficiency virus infection. Neurology 50 1 (1998) 244-251
38. Yaqub B.A., Daif A.K., and Panayiotopoulos C.P. Pancerebellar syndrome in heat stroke: clinical course and CT scan findings. Neuroradiology 29 3 (1987) 294-296
39. Garvey G. Current concepts of bacterial infections of the central nervous system. Bacterial meningitis and bacterial brain abscess. J Neurosurg 59 5 (1983) 735-744
40. Quagliarello V.J., and Scheld W.M. Treatment of bacterial meningitis. N Engl J Med 336 10 (1997) 708-716
41. Perkin G.D., and Murray-Lyon I. Neurology and the gastrointestinal system. J Neurol Neurosurg Psychiatry 65 3 (1998) 291-300
42. Lynch T., Odel J., Fredericks D.N., et al. Polymerase chain reaction-based detection of Tropheryma whippelii in central nervous system Whipple's disease. Ann Neurol 42 1 (1997) 120-124
43. Singer R. Diagnosis and treatment of Whipple's disease. Drugs 55 5 (1998) 699-704
44. Mancini J., Chabrol B., Moulene E., et al. Relapsing acute encephalopathy: a complication of diphtheria-tetanus-poliomyelitis immunization in a young boy. Eur J Pediatr 155 2 (1996) 136-138
45. Sunaga Y., Hikima A., Ostuka T., et al. Acute cerebellar ataxia with abnormal MRI lesions after varicella vaccination. Pediatr Neurol 13 4 (1995) 340-342
46. Klockgether T., Doller G., Wullner U., et al. Cerebellar encephalitis in adults. J Neurol 240 1 (1993) 17-20
47. Hayakawa H., and Katoh T. Severe cerebellar atrophy following acute cerebellitis. Pediatr Neurol 12 2 (1995) 159-161
48. Dangond F., Engle E., Yessayan L., et al. Pre-eruptive varicella cerebellitis confirmed by PCR. Pediatr Neurol 9 6 (1993) 491-493
49. Zifko U., Drlicek M., Senautka G., et al. High dose immunoglobulin therapy is effective in the Miller Fisher syndrome. J Neurol 241 3 (1994) 178-179
50. Nagashima T., Koga M., Odaka M., et al. Clinical correlates of serum anti-GT1a IgG antibodies. J Neurol Sci 219 1-2 (2004) 139-145
51. Jones Jr. H.R., Hedley-Whyte E.T., Friedberg S.R., et al. Primary cerebellopontine multifocal leucoencephalopathy diagnosed premortem by cerebellar biopsy. Ann Neurol 11 (1982) 199-202
52. Brink N.S., and Miller R.F. Clinical presentation, diagnosis, and therapy of progressive multifocal leukoencephalopathy. J Infect 32 (1996) 97-102
53. Will R.G. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br Med Bull 66 (2003) 255-265
54. Ullrich N.J., and Pomeroy S.L. Pediatric brain tumors. Neurol Clin 21 4 (2003) 897-913
55. Zabek M. Primary posterior fossa tumours in adult patients. Folia Neuropathol 41 4 (2003) 231-236
56. Furneaux H.M., Rosenblum M.K., Dalmau J., et al. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med 322 26 (1990) 1844-1851
57. Drlicek M., Bianchi G., Bogliun G., et al. Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: a long-term survey of ovarian cancer patients. J Neurol 244 2 (1997) 85-89
58. Darnell R.B., and Posner J.B. Paraneoplastic syndromes involving the nervous system. N Engl J Med 349 16 (2003) 1543-1554
59. Graus F., Vega F., Delattre J.Y., et al. Plasmapheresis and antineoplastic treatment in CNS paraneoplastic syndromes with antineuronal autoantibodies. Neurology 42 3 Pt 1 (1992) 536-540
60. Bushara K.O., Goebel S.U., Shill H., et al. Gluten sensitivity in sporadic and hereditary cerebellar ataxia. Ann Neurol 49 4 (2001) 540-543
61. Hadjivassiliou M., Davies-Jones G.A., Sanders D.S., et al. Dietary treatment of gluten ataxia. J Neurol Neurosurg Psychiatry 74 9 (2003) 1221-1224
62. Hadjivassiliou M., Grunewald R., Sharrack B., et al. Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics. Brain 126 Pt 3 (2003) 685-691
63. Kono S., Miyajima H., Sugimoto M., et al. Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer. Intern Med 40 9 (2001) 968-971
64. Iwasaki H., Sato R., Shichiri M., et al. A patient with type 1 diabetes mellitus and cerebellar ataxia associated with high titer of circulating anti-glutamic acid decarboxylase antibodies. Endocr J 48 2 (2001) 261-268
65. Mitoma H., Song S.Y., Ishida K., et al. Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase. J Neurol Sci 175 1 (2000) 40-44
66. Lauria G., Pareyson D., Pitzolu M.G., et al. Excellent response to steroid treatment in anti-GAD cerebellar ataxia. Lancet Neurol 2 10 (2003) 634-635
67. Harayama H., Ohno T., and Miyatake T. Quantitative analysis of stance in ataxic myxoedema. J Neurol Neurosurg Psychiatry 46 6 (1983) 579-581
68. Asayama K., Dobashi K., Hayashibe H., et al. Vitamin E protects against thyroxine-induced acceleration of lipid peroxidation in cardiac and skeletal muscles in rats. J Nutr Sci Vitaminol (Tokyo) 35 5 (1989) 407-418
69. Torvik A. Brain lesions in alcoholics: neuropathological observations. Acta Med Scand Suppl 717 (1987) 47-54
70. Fadda F., and Rossetti Z.L. Chronic ethanol consumption: from neuroadaptation to neurodegeneration. Prog Neurobiol 56 4 (1998) 385-431
71. Manto M.U., and Jacquy J. Other cerebellotoxic agents. In: Pandolfo M. (Ed). The Cerebellum and its Disorders (2002), Cambridge University Press, Cambridge 342-366
72. Abele M., Burk K., Schols L., et al. The aetiology of sporadic adult-onset ataxia. Brain 125 Pt 5 (2002) 961-968
73. Gilman S., Little R., Johanns J., et al. Evolution of sporadic olivopontocerebellar atrophy into multiple system atrophy. Neurology 55 4 (2000) 527-532
74. Perlman S.L. Cerebellar ataxia. Curr Treat Options Neurol 2 3 (2000) 215-224
75. Perlman S.L. Symptomatic and disease-modifying therapy for the progressive ataxias. Neurologist 10 5 (2004) 275-289